Boeing of Huntsville awarded another $6.56 billion for missile defense

(U.S. Missile Defense Agency/Flickr)
(U.S. Missile Defense Agency/Flickr)

 

The Boeing Co. in Huntsville, Alabama, just had its Ground-based Midcourse Defense (GMD) development and sustainment contract (DSC) modified to include another $6.56 billion for the program.

The details:

— The Department of Defense announced the contract modification on Wednesday.

— “The scope of work under the current DSC includes development, fielding, test, systems engineering, integration and configuration management, equipment manufacturing and refurbishment, training, and operations and sustainment for the GMD weapon system and associated support facilities,” the Department of Defense said.

— The contract extension, which runs January 2018 through December 2023, is meant for an expansion of capabilities at Fort Greely, Alaska, to complete “the accelerated delivery of a new missile field with 20 additional silos and two additional silos in a previously constructed missile field” and “procurement and deployment of 20 additional Ground Based Interceptors (GBIs).”

— Ballistic missile defense has been one of President Trump’s military priorities.

— The contract extension meets a request that he made to Congress last November, asking for funding for new silos and other improvements at Fort Greely.

— Other companies with Huntsville-based operations are also a part of the contract, including Raytheon Co., Orbital ATK, and Northrop Grumman Corp.

Read more about the Ground-based Midcourse Defense here.

Recent in All News

A New York Times opinion column is putting Alabama’s public schools in the national spotlight, praising the state as a national leader in post-pandemic academic recovery and pointing to its accountability and early literacy policies as a model other states could follow. Opinion columnist Nicholas Kristof wrote that Alabama — along with Mississippi and Louisiana […]

Alabama’s two U.S. senators are backing new bipartisan legislation aimed at increasing transparency in the prescription drug supply chain by requiring country-of-origin labeling on medications and their key ingredients. U.S. Sens. Katie Britt (R-Montgomery) and Tommy Tuberville (R-Auburn) have joined colleagues in introducing the Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base […]